European Heart Journal

Article	Citations
Meet the European Society of Cardiology Gold Medallists 2022	4594
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	3539
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	2776
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	2708
Pulmonary haemodynamics and pulmonary congestion: where are we now?	2646
A rare case of a dorsal mass caused by descending thoracic aortic dissection	2625
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	2473
Intricacies of aortic risk assessment studies: not a simple matter	2251
Bulgarian Society of Cardiology: 50 years on	2174
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	1607
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	1423
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	1231
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	1011
Recent cardiac rehabilitation and its impact on cardiopulmonary exercise test variables in Brazilian cardiac transplant recipients	934
Differences in left atrial stain, endothelial glycocalyx, arterial elasticity and myocardial efficiency between ESUS, lacunar, cardioembolic and atherosclerotic type of stroke	820
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry	702
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	482
Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry	468
Cardiac troponin fragmentation in marathon runners. The MaraCat2 study	458
Echocaridographic assessment of pulmonary hypertension: improving the probability	356
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	346
Cumulative accelerometer-based light physical activity from childhood through young adulthood progressively decreases left ventricular mass in British youth: a 13-year longitudinal study	337
Physiological disease pattern as assessed by PPGI in vessels with FFR and iFR discordance	337
Clinical outcomes of deferred lesions by IVUS versus FFR-guided treatment decision: the FLAVOUR trial substudy	334
Novel cardiovascular magnetic resonance imaging heterogeneity biomarkers to diagnose and predict cardiovascular disease: a UK Biobank CMR strain study	327

T regulatory cells lose their protective phenotype in patients with coronary artery disease (CAD)	298
Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes	290
Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	287
Association between the changes in walking speed during 6 months after discharge and subsequent prognosis in older patients with heart failure: report from a multicenter prospective cohort study	286
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	284
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team	278
Deep learning for fully automated echocardiographic measurements of left ventricular wall thickness and chamber dimensions in the parasternal long-axis view	264
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	232
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	231
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	225
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	223
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	215
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	212
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching	211
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function	206
Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries	205
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?	203
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	200
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	200
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	191
Factors for incorrect automated atrial fibrillation identification in large-scale screening	189
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	188
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	184
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	174
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	174
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	171
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	170
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	170
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	164
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	163
Impact of the thin-walled sheath on the distal radial artery occlusion: a randomized trial	162
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation	162
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	162
The role of seasonal influenza immunisation in cardiovascular care: a survey of cardiologists	160
Comparative study of the effects of left ventricular and biventricular pacing on indices of cardiac function and clinical status of heart failure patients: preliminary results of READAPT study	160
Acute deterioration in dyssynchrony and systolic function from Lot-CRT to LBBB pacing	156
Ultra-processed food consumption and risk of cardiovascular mortality in Australia: preliminary results from prospective observational study	156
Dynamic changes of excessive trabeculation in dilated cardiomyopathy: a longitudinal cardiovascular magnetic resonance study	151
Comparison of fully angiography-derived versus a hybrid of angiography and pressure-wire-derived approach to assess coronary microvascular resistance: the OxAMI-Hybrid study	150
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarction	148
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart	147
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	142
Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients	142
Endothelial dysfunction in acute coronary syndrome: a complex association with cardiovascular risk factors, sleep quality and cardiorespiratory capacity	140
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	140
Feasibility and efficacy of a novel 6 french sheathless guiding catheter equipped with peel-off type external dilator for PCI with distal radial approach - a Japanese multicenter study	140
Survival in STEMI in resource limited settings - obstacles and potential solutions. Critical lesson learnt thorough a prospective observational study	139
Long-term outcomes following DCB vs. DES for ISR treatment	138
Associated factors and clinical implications of dynamic changes in late gadolinium enhancement after acute myocarditis	137
Plaque phenotyping using deep learning in optical coherence tomography imaging	135

Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	134
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation	134
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	134
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	134
NOAC in adult congenital heart disease patients: a single-center experience	133
Usefulness of CineECG method in identification of P-wave morphology variants in an elderly epidemiologic cohort	132
Echocardiography in acute pulmonary embolism for the prediction of subsequent CTEPH	131
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	130
Phenotyping coronary plaque by computed tomography in premature coronary artery disease	129
Impaired right ventricular strain is associated with worse prognosis in patients with liver cirrhosis	127
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention	126
Discovering an unknown risk. The unnoticed, potientially life-threatening risk to people with an inherited cardaic arrhythmia during the non-cardiac perioperative period.	124
How can the detection of AF be improved? Insights from patient journeys and primary care clinicians	123
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study	122
Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions	122
The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT	122
Prediction of outcome in malignant hypertension patients using machine learning: a report from the West Birmingham malignant hypertension registry	121
Safety of electrophysiological study in atrioventricular block risk stratification in new-onset persistent left bundle brunch block following transcathether aortic valve implantation	120
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	119
Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease	118
Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry	116
Quantifying cardiac tissue heterogeneity using high-density grid catheter: validation in porcine model	115
Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial	114
Blood pressure polygenic risk scores associate with resistant hypertension in individuals with type 1 diabetes	113
Calculation of intraprocedural hemodynamics with computational functional dynamic in mitral valve edge-to-edge repair	112
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	112
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice	111
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	111
ARNI effects in HFrEF. Risk reduction beyond LVEF	110
Association between quantitative flow ratio and non-target-vessel-related events before planned staged percutaneous coronary intervention in patients with acute coronary syndrome	108
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period	107
Cardiometabolic outcomes in patients with overweight and obesity undergoing weight loss trials : a network meta-analysis	107
Microtransesophageal echocardiographic guidance of patent foramen ovale percutaneous closure	106
Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy	106
Prognostic role of early cardiac magnetic resonance in myocardial infarction with non-obstructive coronary arteries	106
Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction	105
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation	105
Influence of radiotherapy on cardiac implantable device lead parameters	103
Ten years survival benefit of CABG or PCI based on individual prediction	102
Machine learning can accurately detect abnormal aortic valves in CMR	102
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: design, rationale, and first results of the Zabrze-Lip(a)R Registry	101
Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm	101
Left atrial function and long-term survival after cardiac resynchronization therapy	101
Lipoprotein(a) and cardiovascular prognosis of familial dyslipidemias: data from a 10-year follow-up study	101
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry	100
Machine learning model using cardiovascular magnetic resonance to predict cardiovascular events in asymptomatic patients with known CAD	100
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation: observations from the GARFIELD-AF registry	98
Microvascular dysfunction and absolute coronary blood flow after percutaneous coronary intervention of a chronic total occlusion	98
Effect of sacubitril/valsartan and empagliflozin on systemic inflammation and scar remodeling in a swine model of myocardial infarction	97
MINOCA due to vasospasm compared to other mechanisms: patients characteristics, evolution and prognosis	96
Variations in atrial fibrillation screening after ischemic stroke or transient ischemic attack in Sweden	96
Combined cardiopulmonary test and exercise Doppler echocardiography in systemic sclerosis	96
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?	95
Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study	95
Pulmonary artery aneurysm in pulmonary arterial hypertension associated with congenital heart disease	94
Targeting Neurofibromin 2 (NF2) prevents endothelial dysfunction in obesity: a study in mice and humans	94
Primary care screening and prevention of heart failure coordinated by cardiologist in rural areas	94
Anticoagulation and stroke in hospitalized patients newly diagnosed with secondary atrial fibrillation: a population-based cohort study	93
The impact of hydrostatic pressure on fractional flow reserve in saphenous vein grafts	93
Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS	92
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study	92
Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease	91
Early quantitative pupillary response parameters have high predictive value for 30-day mortality in patients resuscitated from out-of-hospital cardiac arrest	89
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry	89
Efficacy of controlvit as a complementary strategy in reducing hospitalizations in patients with heart failure. Randomized clinical trial	89
Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: insights From the IMPEDANCE-HF Trial	88
Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry	88
A novel technology for heart failure that utilizes the respiratory effort to shift fluids from the lung and alleviate cardiac workloads; feasibility study in sheep	88
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction	87
Demographic, clinical characteristics, managements strategies and in-hospital outcomes of patients enrolled in prospective nationwide SCAD registry	87
Ultrasonographic and functional evaluation of forearm circulation with occluded radial artery	86
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study	85
Various arrhythmia types and their day-by-day occurrence rates over a 14-day period using a P-wave sensitive ambulatory ECG monitored population	85
Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow up	83
Ethnic disparity in the care and management of non-ST-segment elevation myocardial infarction and its impact on short-term and long-term survival: a long-term study of a national registry	83
Estimation of antihypertensive effect after initiating continuous positive airway pressure treatment in Japanese patients with sleep disordered breathing	83
Biomarker profiles of favorable ventricular remodeling in heart failure patients with reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial	82
Safety and efficacy of cerebral embolic protection devices in transcatheter aortic valve implantation: a meta-analysis	82
Sequential left ventricular electro-mechanical changes in left bundle branch pacing vs right ventricular pacing a two-center study	82
Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes	80

Guideline-directed medical therapy and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction	80
Participation of epicardial connection in transverse conduction across the crista terminalis in patients with upper and lower loop reentry atrial tachycardias	80
COVID-19 vaccination in the pediatric age and risk for myocarditis	80
Afterload mismatch is associated with gender mismatch and negatively affect long-term outcome after heart transplant	79
Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy	79
Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis	79
Figuring out complete left ventricular reverse remodeling in tachycardiomyopathy	78
Routine use of 3-dimensional zoom modality with 2-dimensional transesophageal echocardiography to decide the candidacy for transcatheter device closure of atrial septal defect	77
Bipolar ablation of refractory ventricular arrhythmias using a novel dedicated adapter. A multicenter study	77
Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels	77
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry	77
Computed tomography plaque analysis identifies residual inflammation in recent acute myocardial infarction patients	77
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	76
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	76
Infective endocarditis - characteristics and long-term outcomes in patients with congenital heart disease are distinct from those without congenital heart disease	76
Influence of lead extraction on tricuspid valve function	76
Cardiac complications as a major predictor of in-hospital death in infective endocarditis using machine-learning algorithm analysis	75
Epidemiology, clinical characterization, and outcomes for heart failure with improved ejection fraction	74
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement	74
Interaction of inherited genetic variants in the NLRP3 inflammasome/IL-6 pathway with acquired clonal hematopoiesis to modulate mortality risk in patients with HFrEF	74
Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)	73
Coronary rotational atherectomy in patients with severe aortic stenosis	73
High-sensitivity C-reactive protein is associated with cardiac dysfunction and morbidity in a community-based cohort	73
Functinal assessment in Angina and Non-Obstructive Coronary Arteries (ANOCA) patients: from Microvascular Resistance Reserve (MRR) to different subtypes of Coronary Microvascular Dysfunction (CMD)	73
Telomere length across spectrum of metabolic health	72
Refining the prognosis of patients with AF using 3D transesophageal echocardiography of the left atrial appendage	71
Beyond secondary prevention drugs: added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome	71
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis	71
Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: a systematic review and meta-analysis of 38 studies	71
Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017	71
The correlation between angio-IMR and thermodilution-based IMR in patients with ischemia and non obstructive coronary arteries	70
Cardiac troponin T and I are differentially associated with myocardial fibrosis assessed by cardiac magnetic resonance imaging	70
Strategic management to optimize response to cardiac resynchronization therapy registry	70
Ventriculo-arterial coupling parameters by cardiac magnetic imaging are associated with outcome in patients with a systemic right ventricle	69
Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure	69
Impact of QRS complex fragmentation on all-cause mortality before and after cardiac resynchronization therapy	69
Heart failure therapy in new onset heart failure versus chronic heart failure: an analysis of 90,383 patients from the Swedish Heart Failure Registry (SwedeHF)	69
Automated non-invasive quantification of myocardial work using 3D echocardiography and validation with invasive catheter measurements	69
Disparities in the access to atrial fibrillation ablation in Denmark	68
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement	68
Spermidine attenuates left ventricular dysfunction in estrogen deprived aging rats through mitigating lipid peroxidation and mitochondrial dysfunction	68
Acute and long-term success of left atrial anterior line and mitral isthmus line ablation in patients after mitral valve surgery	68
Impact of proNGF/NGF-NGFR-axis on the regulation of arterial remodelling	67
Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers	67
Mortality and heart failure in patients with severe tricuspid regurgitation. Impact of RV volumes and function by CMR.	67
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation: an updated systematic review and meta-analysis	67
Dissociation of LA volume and deformation is a hallmark of ATTR-CA	67
Disease trajectories following myocardial infarction: insights from process mining of 145 million hospitalisation episodes	67
Agreement between two independent raters in identifying exercise oscillatory ventilation in patients with heart failure	67
Results from a nationwide atrial fibrillation screening effort in Belgium	67
Left ventricular early diastolic strain rate and cardiovascular outcome in patients with left ventricular non-compaction phenotype	67
Progression, regression and redefining the treatment response – cardiac magnetic resonance with T1 and extracellular volume mapping in cardiac light-chain amyloidosis	66
Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study	66
Ten year survival after an acute heart failure episode	66
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis	66
Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry	66
Spin-lock based magnetic field sensing: a non-invasive MRI method for spatially resolved imaging of cardiac conduction?	66
A comparative analysis of conventional echocardiographic findings among different heart failure stages and phenotypes: insights from the national echocardiographic society registry	66
Effects of Sacubitril/Valsartan on all-cause hospitalizations in heart failure: participant-level pooled analysis of PARADIGM-HF and PARAGON-HF	66
Pnn deficiency alters expressions of calcium handling proteins and impairs nuclear envelope structure in cardiomyocytes	66
Morphology-Voltage-P-wave duration (MVP) score in prediction of incident atrial fibrillation in an elderly epidemiologic cohort	65
Long-term prognosis after ST-elevation myocardial infarction according to the Canadian Cardiovascular Society classification of tissue injury severity in acute myocardial infarction	65
Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate	65
Outcomes of chronic total occlussion recanalization in patients with prior bypass-surgery: an updated systematic review and meta-analysis of real world registries	64
Routine chest X-ray post cardiac implantable electronic device implantation: is it really required? Experience from a tertiary centre	64
Improving the prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy by adding plasma SVEP1 to conventional clinical model including NT-proBNP	64
Associations of maternal exposure to multiple plasma metals with the risk of fetal congenital heart defects: a prospective nested case-control study	63
Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy	63
The sooner the better? What is the optimal timing for coronary angiography in high-risk non-ST-elevation acute coronary syndrome	63
Simulating atrial fibrillation patterns and screening strategies using virtual patient-level models	62
Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 s	62
Reducing the burden of inconclusive smart-device single-lead ECG tracings via a novel atificial intelligence algorithm	62
Remodeling of adult rat heart subjected to pressure overload from the neonatal period is dependent on the sex	62
24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?	62
Expanding CAD assessment beyond coronary arteries: can body composition offer valuable insights?	61
Activation patterns of intracellular signaling pathways in cardiac hypertrophy induced by different exercise modes in rats	61
Setting the standard: Massimo Piepoli takes on lead editorial role	61
Outcomes benefit in asymptomatic patients with moderate aortic valve stenosis followed up in heart valve clinics	61
Estrogen-induced phenotype in hiPSC-derived cardiomyocytes of a woman affected by both Long QT Syndrome Type 2 and Polycystic Ovary Syndrome	60
Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)	60
Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study	60
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age	60
Comparative effects of ranolazine and trimetazidine on cardiac structure and exercise capacity in a healthy rat model: a new doping agent?	59
Leveraging global coronary flow assessments to inform revascularization benefit in chronic coronary disease: time to test total heart flow	59
Cardiac troponin elevation and mortality in takotsubo syndrome: new insights from the International Takotsubo (InterTAK) registry	59
Ablation therapies for paroxysmal atrial fibrillation: a systematic review and patient-level network meta-analysis	59
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	59
Global burden of metabolic diseases: data from Global Burden of Disease 2000-2019. A cosortium of metabolic disease	59
From a club of friends to an institution: past successes and future challenges for the European Society of Cardiology	57
Comparison of rapid test for high-sensitivity troponin I with laboratory high-sensitivity troponin T in patients with acute chest pain - a prospective monocentric study	57
Preserved left ventricular ejection fraction with abnormal myocardial work in sepsis	57
Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry	57
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation	57
The European Cardio Summit in Romania	57
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study	57